Bringing together expertise from across the Centres, the Network Groups provide the ECMC research community with a forum for peer-to-peer support, training and development, improving quality and standards, and tackling particular research challenges in early phase and translational research.
UKTCPN brings together a unique blend of expertise for research in cancer chemoprevention including scientists, clinicians, epidemiologists, statisticians and specialists in primary care, diet and nutrition.
As a primary interface between the radiopharmacy community and regulatory authorities, the group aims to provide a common understanding of regulatory requirements for clinical trials that involve radiopharmaceuticals.
The aim of this group is to bring together, and help develop, junior investigators across all disciplines of translational research within the ECMCs.
The QATS Network Group supports translational research, with a focus on high levels of quality and regulatory compliance.
The nurses promote quality care for patients taking part in early phase research through peer support, training and guidance for those involved in early phase and translational research.
The CMP aims to personalise and improve treatments by enabling access to pathology resources and expertise in new biomarker-led studies.